Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Abstract Full Text (PDF, 342K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Vincent, M. S. Articles by Budd, R. C. Search for Related Content PubMed PubMed Citation Articles by Vincent, M. S. Articles by Budd, R. C. Pubmed/NCBI databases Medline Plus Health Information Joint Disorders Lyme Disease Social Bookmarking                            What's this?

Articles

Apoptosis of Fas^high CD4⁺ Synovial T Cells by Borrelia-reactive Fas-ligand^high T Cells in Lyme Arthritis

Michael S. Vincent^*, Karen Roessner^*, David Lynch, David Wilson^*, Sheldon M. Cooper^*, Jurg Tschopp, Leonard H. Sigal^||, and Ralph C. Budd^*

From the ^* Divisions of Immunobiology and Rheumatology, Department of Medicine, The University of Vermont College of Medicine, Burlington, Vermont 05405-0068; Immunex Corporation, Seattle, Washington 98101; Institute of Biochemistry, University of Lausanne, Swiss Institute for Cancer Research, Epalinges, Switzerland; ^|| Division of Rheumatology and Connective Tissue Research, Department of Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903

	Abstract

Top Abstract Materials and Methods Results Discussion References

 
The function of the minor subset of T lymphocytes bearing the T cell antigen receptor is uncertain. Although some T cells react to microbial products, responsiveness has only rarely been demonstrated toward a bacterial antigen from a naturally occurring human infection. Synovial fluid lymphocytes from patients with Lyme arthritis contain a large proportion of cells that proliferate in response to the causative spirochete, Borrelia burgdorferi. Furthermore, synovial T cell clones express elevated and sustained levels of the ligand for Fas (APO-1, CD95) compared to β T cells, and induce apoptosis of Fas^high CD4⁺ synovial lymphocytes. The findings suggest that T cells contribute to defense in human infections, as well as manifest an immunoregulatory function at inflammatory sites by a Fas-dependent process.

While most T lymphocytes express a TCR composed of and β chains, a subpopulation of T cells bearing alternate and chains exists as a minor subset of peripheral blood lymphocytes (PBL)¹ (1). While the function of T cells is uncertain, a clue may lie in their increased proportion at epithelial barriers, during certain infections, and at sites of chronic inflammation such as synovial tissue in rheumatoid arthritis (2–7). Some T cells respond to bacterial products and can be identified after infection of mice with particular bacteria (8–15). However, in humans, leprosy is the only infectious disease to date in which cells from affected individuals have been shown to respond to the causative organism (9).

T cells frequently manifest cytolytic activity toward a broad array of target cells (2, 16). Such a spectrum of cytolysis might occur when a target molecule is widely expressed, such as the Fas antigen (APO-1, CD95) (17). Fas is a 45-kD cell surface molecule that mediates apoptosis and is a member of a family of molecules that includes the type I receptor for TNF. Fas is one of the principle components responsible for T cell–mediated cytotoxicity (18–20). Expression of mRNA for the Fas ligand (Fas_L) was originally described as being transiently expressed by activated β T cells, although higher mRNA levels were noted in T cells (21). More recent findings have noted constitutive expression of Fas_L by nonlymphoid cells, including Sertoli cells of the testis (22) and certain components of the eye (23). Fas_L expression by these tissues parallels their ability to suppress immune-mediated inflammation. These collective observations suggested that T cells in Lyme arthritis might respond to Borrelia burgdorferi as well as contribute to regulation of the synovial inflammatory infiltrate.

	Materials and Methods

Top Abstract Materials and Methods Results Discussion References

 
Patients.
Lyme arthritis patients came from areas endemic for Lyme disease and were followed at the Lyme Disease Clinic at the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School. All patients had histories, exams, and serologies consistent with Lyme arthritis, including Borreliaspecific antibody titers that were higher in synovial fluid relative to serum. Synovial fluid lymphocytes were examined from seven patients with Lyme arthritis of 6-mo to 3.2-yr duration.

Flow Cytometry.
Lymphocytes were isolated from peripheral blood or synovial fluid by Ficoll–Hypaque centrifugation. Cells were stained with the indicated fluorochrome-conjugated antibody at 4°C for 30 min. Antibodies were specific for TCR-β (JOVI-1; Ancell Corp., Bayport, MN), TCR- (5A6.E9; T Cell Sciences, Inc., Cambridge, MA), TCR-V1 and TCR-V2 (AB and BB3, respectively, courtesy of Dr. Alessandro Moretta, University of Genoa, Genoa, Italy), CD4 (SFCI12T4D11; Coulter Corp., Hialeah, FL), CD8 (SFCI21Thy2D3; Coulter Corp.), Fas (M38) (24) and Fas_L (polyclonal C-20; Santa Cruz Biotechnology, Santa Cruz, CA; or monoclonal A11 [25]). Surface staining for Fas_L was performed by one of three methods. The first approach used a fusion protein composed of the extracellular domain of murine Fas linked to the human Ig Fc portion (Fas-Fc) (26). This was followed by goat anti–human Fc–biotin and then avidin–phycoerythrin. Control staining was accomplished by staining for surface IL4 using an IL4 receptor–Fc fusion protein. Alternatively, surface Fas_L was measured using either a rabbit antiserum to the extracellular carboxyl-terminal portion of human Fas_L and purified on a Fas_L sepharose column (C-20), or monoclonal antibody A11 that recognizes both mouse and human Fas (25). To measure Fas_L induction, cells were examined 3 h after stimulation with PMA (10 ng/ml) and ionomycin (250 ng/ml), in the absence or presence of metalloprotease inhibition using 5 mM EDTA (27). Samples were analyzed on a Coulter Elite flow cytometer (Coulter Corp.) and at least 2 x 10⁴ events were accumulated for analysis.

Proliferation Assays and Derivation of Lyme Synovial T Cell Clones.
Synovial fluid lymphocytes were cultured in AIM-V serum-free medium (GIBCO BRL, Gaithersburg, MD) in either bulk cultures (10⁶/ml) for phenotyping, or in round-bottomed microtiter wells (10⁵/well) for proliferation assays. Cells were stimulated with 3 µg/ml of a sonicate of B. burgdorferi grown in BSK II medium as previously described (28). Triplicate cultures were pulsed with ³H-TdR during the last 18 h of a 6-d culture, harvested, and counted. From parallel cultures, responding cells were cloned at 0.3 cells/well in AIM-V with 5% FCS in the presence of irradiated PBL (3 x 10⁵/well), human recombinant IL2 (10 U/ml), and 3 µg/ml of B. burgdorferi sonicate. Responding wells were phenotyped and the cells expanded by restimulation at 10-d intervals.

PCR Analysis of Synovial Fluid T Lymphocyte V Repertoire.
Semi-quantitative PCR was performed on samples using cDNA prepared from oligo-dT–primed RNA and reverse transcriptase (GIBCO BRL) as previously described (29). The 5' V- and C-specific primers are modifications of published sequences (30) as follows: V1: 5'-AGCAACTTCCCAGCAAAGAG-3'; V2: 5'-AGGAAGACCCAAGGTAACACAA-3'; V3: 5'-CACTGTATATTCAAATCCAGA-3'; V4: 5'-TGACACCAGTGATCCAAGTTA-3'; V5: 5'-CTGTGACTATACTAACAGCATGT-3'; V6: 5'-TATCATGGATTCCCAGCC-3'; 5'C: 5'-CTTGTCTGGTGCAG-3'; 3'C: 5'-CTTCACCAGACAAGCGACAT-3'. A PCR reaction master mix that was common to all samples contained 100 mM Tris HCl, pH 8.3, 500 mM KCl, 2 mM MgCl₂, 200 µM dNTPs, with 25 pmoles of 3' C primer, 2.2 µCi -³²P-dCTP, and 2.5 U Taq polymerase (GIBCO BRL) per tube. The final volume was 100 µl and contained 10 ng cDNA, and 25 pmoles of individual V primer. Samples were run on a thermocycler (model 9600; Perkin-Elmer Corp., Norwalk, CT) for 24 cycles using the parameters: cycle 1: 94°C x 3 min, 50°C x 45 s, 72°C x 1 min; cycles 2–23: 94°C x 30 s, 50°C x 45 s, 72°C x 1 min; cycle 24: 94°C x 30 s, 50°C x 45 s, 72°C x 7 min. Samples were resolved on a 29 cm 10% polyacrylamide gel containing 7 M urea in TBE buffer and electrophoresed at 80 V for 18 h. The gel was dried and developed on an analyzer (Betascope 603; Betagen, Waltham, MA). The percentage expression of each V was assigned by dividing the actual cpm for a specific V by the total cpm for V1–V6 after correction for the total C message in each sample.

Assay of Cytotolytic Activity.
Fas^low variants of the wild-type Jurkat T cell line, H7 (3% normal surface Fas levels) and B4 (1% normal Fas levels), were derived through irradiation mutagenesis using five doses of 200 Rads each, delivered at 5-d intervals. After each irradiation, cells were cultured in wells coated with lytic anti-Fas antibody (M2, 3 µg/ml)(24). The Fas^low variants and wild-type Jurkat cells were incubated with ⁵¹Chromium (⁵¹Cr) for 1 h, washed, and then mixed at various effector/target ratios with cloned V1 cells in a total volume of 200 µl. After a 4-h incubation at 37°C, 100 µl of supernatant were removed and counted for emission. Spontaneous release was determined from labeled targets in the absence of effector cells. Maximum release was determined by lysing target cells with 1.0 N HCl. The percentage of specific ⁵¹Cr release was calculated as:

.

Blocking studies of cytolysis were performed using either specific antibodies at the concentrations indicated, or Fas-Fc fusion protein (10 µg/ml) preincubated with appropriate cells for 30 min before beginning the cytolysis assay. Antibodies used were specific for TCR- (5A6.E9), HLA class I (W6/32; Accurate Chemical and Science Corp., Westbury, NY), HLA class II (L243; Becton Dickinson & Co., Immunocytometer, Sys., Mountainview, CA), LFA-1 (R7.1; Biosource International, Camarillo, CA), or Fas (M38).

TUNEL Assay for Apoptosis.
Cells were initially stained for expression of surface , CD4, or CD8 and then fixed for 15 min in 1% paraformaldehyde. Cell membranes were then permeabilized for 15 min using 70% ethanol at 4°C. Samples were incubated at 37°C for 1 h in 100 µl containing 10 U terminal deoxyribosyltransferase and 0.5 nM dUTP-biotin (Boehringer Mannheim Biochemicals Corp., Indianapolis, IN) (31, 32). Specimens were washed twice with PBS/1% BSA and incubated with a 1:50 dilution of avidin-tricolor (Caltag Labs., South San Francisco, CA) at 4°C for 30 min. Cells were washed twice and analyzed by flow cytometry.

	Results

Top Abstract Materials and Methods Results Discussion References

 
Reciprocal Changes in Synovial Fluid CD4⁺ and T Cells with Borrelia Stimulation.
Synovial fluid lymphocytes were examined from seven patients with Lyme arthritis of 6 mo to 3.2-y duration. These contained a predominance of CD4⁺ over CD8⁺ β T cells in only four of seven cases (Fig. 1 A, Table 1), compared to a consistent CD4 predominance in PBL. Also present in the synovial mononuclear cells was a remarkable percentage of T cells (18.9 ± 6.8%) (Fig. 1 A, Table 1), compared to 1–5% in PBL (Reference 1 and see Fig. 3). The synovial population was largely devoid of surface CD4, and only a minor proportion (20% on average) expressed low to intermediate levels of CD8 (Fig. 1 B). In addition, whereas T cells from PBL express predominantly the V2 gene product (33), Lyme arthritis synovial fluid cells were primarily of the V1 subset, with lesser proportions of V2 and V3 cells. This was determined by both flow cytometry using V-specific antibodies (Fig. 1 A), and semi-quantitative PCR using specific V primers (Fig. 2).

View larger version (75K): [in this window] [in a new window] [Download PPT slide]   Figure 1 Reciprocal shifts in the percentages of versus CD4+ T cells after stimulation by B. burgdorferi of Lyme arthritis synovial fluid T cells. Synovial fluid mononuclear cells, isolated by Ficoll-Hypaque centrifugation, were analyzed either freshly isolated or 6 d after stimulation with a 3 µg/ml sonicate of B. burgdorferi. (A) Flow cytometric analysis of synovial fluid mononuclear cells reveals a prominent population of cells that expresses mostly V1 and expands dramatically following stimulation with B. burgdorferi. The numbers in the histograms indicate the percent of positively stained cells. (B) Synovial fluid cells are predominantly CD4– CD8–. FACS® staining demonstrates that cells are largely devoid of CD4 and only a minor subset expresses low to intermediate levels of surface CD8.

 

View this table: [in this window] [in a new window]   Table 1 Phenotypic Changes in Lyme Arthritis Synovial Fluid T Cells following Borrelia Stimulation

 

View larger version (35K): [in this window] [in a new window] [Download PPT slide]   Figure 3 High level expression of surface Fas by synovial CD4+ cells. Mononuclear cells from freshly isolated Lyme arthritis synovial fluid or PBL were immunofluorescently stained for surface expression of Fas and either CD4, CD8, or . Number insets represent percent of positively stained cells. Only the CD4+ subset of synovial fluid cells contains a large proportion of Fashigh cells.

 

View larger version (58K): [in this window] [in a new window] [Download PPT slide]   Figure 2 Semi-quantitative PCR using 5' primers specific for V1V6 or C, and a 3' primer specific for C. (A) Actual polyacrylamide gel, imaged on a Betascope, of the V bands for Lyme synovial fluid mononuclear cells either freshly isolated (lane 1) or six days after culture with B. burgdorferi (lane 2). No V product was detected from PBL (lane 3) using the parameters of this assay. At the right side of the gel are the C products from the same three specimens. In addition, a control C product, C , is shown from a V1 clone. (B) Graph of the quantitation of the Betascope results for the synovial fluid lymphocytes freshly isolated (SF 0') or after culture with B. burgdorferi (SF + Bb). Each V is displayed as a percentage of the total V cpm.

 
Stimulation of Lyme arthritis synovial fluid mononuclear cells with a sonicate of B. burgdorferi (strain N40) induced vigorous proliferation (Table 1), yielding a two- to threefold increase in cell number over 6 d. During this period, the composition of T cell subsets shifted considerably. Although the percentage of CD8⁺ cells changed only slightly, there was frequently a striking loss in the proportion of CD4⁺ cells by as much as threefold. Thus, despite the increase in total lymphocyte number during the 6-d culture, there was frequently little change or even a decrease in the absolute number of CD4⁺ cells, as illustrated by patient no. 2 in Table 2. This was paralleled by a reciprocal increase in T cells, in some cases to as much as 50% of the cultured synovial lymphocytes (Fig. 1, Table 1). These continued to be mostly V1 cells as determined by both antibody (Fig. 1 A) and PCR (Fig. 2) analysis.

View this table: [in this window] [in a new window]   Table 2 Changes in Absolute Numbers of Synovial T Cell Subsets with Borrelia Stimulation

 
The loss of CD4⁺ synovial cells might have resulted from unresponsiveness of this subset to B. burgdorferi, and hence overgrowth by the CD8⁺ and ⁺ subsets. However, this seems unlikely since we have previously observed that PBL also proliferate strongly to B. burgdorferi with an expansion of predominantly CD4⁺ cells (28). Alternatively, because PBL contain only a small proportion of cells (1), the subset might be responsible for the loss of CD4⁺ cells in Borrelia-activated synovial cultures. Consistent with this notion was the one case (patient no. 6) where the percentage of T cells did not increase following stimulation with B. burgdorferi. In this instance, the proportion of CD4⁺ cells actually increased from 36.5 to 51.4% (Table 1).

Synovial CD4⁺ Cells are Fas^high Whereas Synovial T Cell Clones are Fas_L^high.
To more directly address the possibility that synovial cells might be cytolytic toward the CD4⁺ subset, T cell clones were derived from synovial fluids of two Lyme arthritis patients using a sonicate of B. burgdorferi and irradiated autologous PBL. A panel of 18 Borreliaresponsive clones was established, the majority of which express V1 and lack surface CD4 and CD8. DNA sequencing of the chain from seven clones confirmed that they all express V1, but were otherwise each unique and contained varying degrees of N region diversity (Roessner, K., manuscript in preparation).

T cells frequently manifest cytolytic activity toward a broad array of target cells (2, 16). Such a spectrum of cytolysis might occur when a target molecule is widely expressed, as is the case with the apoptosis-inducing molecule, Fas (17). As shown in Fig. 3, Fas expression by fresh CD4⁺ PBL was low to negligible, but was present on a large proportion of CD4⁺ synovial lymphocytes. By contrast, the CD8⁺ and ⁺ subsets of PBL or synovial lymphocytes displayed considerably lower levels of Fas.

Surface expression of Fas_L protein by B. burgdorferi–reactive and CD4⁺ β T cell clones was examined by flow cytometry using two methods, a Fas-Fc fusion protein as well as a purified anti–human Fas_L rabbit antiserum. Control staining for Fas-Fc was determined using a human IL4 receptor-Fc (IL4R-Fc) fusion protein (as surface-bound IL4 would not be anticipated for a secreted cytokine). Fig. 4 A (column 3) illustrates results of staining using the FasFc fusion protein, on represetative β (114B) and (2.11) synovial T cell clones. By this method, surface Fas_L protein was expressed on a considerably higher proportion of the cells than on the B. burgdorferi–reactive β T cell clones seven days after the last stimulation. Similar findings were seen with an additional two β and two synovial T cell clones. In contrast, the levels of surface Fas antigen on the clones were somewhat less than on the β clones, (Fig. 4 A, column 4).

View larger version (64K): [in this window] [in a new window] [Download PPT slide]   Figure 4 Lyme arthritis synovial clones express high levels of FasL. (A) Surface FasL expression using a Fas-Fc fusion protein (column 3) is shown for a B. burgdorferi–reactive β T cell clone (114B) and a synovial clone (2.11). Negative staining controls included either second step fluorescein–anti-Fc antibody alone (column 1), or initial staining with IL4R-Fc followed by second step anti-Fc antibody (column 2). Column 4 indicates the levels of Fas expression by the same clones. (B) Surface FasL expression detected by an anti–human FasL rabbit antiserum (C-20) purified using a FasL-sepharose column. Cell lines included the T cell leukemic line, molt 4, and the β and T cell clones used in A. Shown is the control staining using rabbit immunoglobulin ( faint line) superimposed on the staining with the anti-FasL antibody (dark line). T cell clones were examined either seven days after the last stimulation with B. burgdorferi (unstimulated ), or 3 h after activation with PMA and ionomycin (iono). Cells were also analyzed in the absence or presence of the metalloprotease inhibitor EDTA in an effort to block degradation of surface FasL (27). Open numbers in histograms represent the percent of positive cells above background staining. Numbers in parentheses indicate the mean fluorescence intensity of the positively stained cells.

 
The anti-Fas_L antibody confirmed the disparity in surface Fas_L expression between synovial versus β T cell clones. Fig. 4 B (column 1) shows that 7 d after antigenic stimulation of the Borrelia-reactive β (114B) and (2.11) clones, surface Fas_L was present on the clone, but was only marginally detectable on the β clone. This finding was consistent for three β and three clones studied. However, the β clones were capable of induction of Fas_L upon stimulation, as shown after 3 h of activation with PMA and ionomycin. In agreement with a recent report (27), Fas_L expression on the T cell line, Molt 4, was enhanced by blocking metalloprotease activity with EDTA (Fig. 4 B, column 4). This was less consistently observed for the β T cell clones, and was not observed for the clones. It was particularly striking that the levels of Fas_L on the clones remained detectable for at least 10 d following stimulation with B. burgdorferi (Fig. 4 B, column 1). This is in distinct contrast to β T cells which express Fas_L only transiently after activation (21; Roessner, K., unpublished observations).

Synovial cells induce apoptosis of CD4⁺ cells in a Fasdependent manner.
To further explore whether the Lyme arthritis synovial fluid T cell clones might be cytolytic toward T lymphocytes expressing high levels of surface Fas, the Jurkat T cell line was initially used as a representative Fas^high target. Fig. 5 A shows that the clones manifested very efficient cytolytic activity toward Jurkat cells, with 50% maximal lysis achieved at an effector/target ratio between 10:1 and 3:1. This finding was remarkably consistent for each of five different V1 clones tested from two patients. In contrast, Borrelia-reactive CD4⁺ β T cell clones manifested little, if any, cytolysis of Jurkat cells (data not shown). Cytolysis by the clones was not inhibited by antibodies to TCR-, HLA class I or II, but was blocked by anti–LFA-1 antibody (Fig. 5 C ), supporting the notion that cytolysis was dependent on cell contact.

View larger version (107K): [in this window] [in a new window] [Download PPT slide]   Figure 5 Lyme arthritis synovial fluid V1 T cell clones are highly lytic in a Fas-dependent manner. Effector V1 clones were combined at the ratios indicated with 51Crlabeled Jurkat target T cells in a four h cytolytic assay. (A) Comparison of cytolytic activity toward wild-type Fashigh Jurkat T cells (closed squares) compared with two Faslow Jurkat variants, H7 (open squares) and B4 (open circles), which express, respectively, 3 and 1% of surface Fas levels observed on wild-type Jurkat cells. (B) Level of Fas expression on wild-type Jurkat T cells and two variants, H7 and B4, selected by repeated irradiation and culture in the presence of lytic anti-Fas antibody, M2. Number insets indicate the mean fluorescence intensity of the gated area. (C ) Attempts to block cytolytic activity using antibodies to HLA class I (closed squares), HLA class II (open squares), TCR- (open circles), and anti–LFA-1 (closed triangles). The anti–LFA-1 study was part of a separate experiment in which the baseline cytolysis was 42%. (D) Ability of various concentrations of nonlytic anti-Fas antibody M38 to inhibit cytolysis of wild-type Jurkat cells by the V1 clones. Cytolysis assay was also performed in the absence (closed squares) or presence (open squares) of 2.5 mM EGTA, an inhibitor of calcium-dependent perforin activity (18). Lysis in the presence of control IgG antibody (10 µg/ml) is shown by the closed triangle. (E ) Inhibition of Jurkat cytolysis by the V1 clones 16 and 2.11 in the presence of 10 µg/ml of either anti-Fas antibody M38, Fas-Fc fusion protein, both, or IL4R-Fc fusion protein.

 
The potential contribution of Fas to cytolysis by cells was examined using three approaches. Initially, two Fas^low variants of Jurkat cells, H7 and B4, were independently derived by radiation mutagenesis followed by selection with lytic anti-Fas antibody, M2. H7 expresses 3% of the levels of Fas found on wild-type Jurkat cells, whereas B4 displays 1% (Fig. 5 B). Fig. 5 A demonstrates that the efficiency of cytolysis of both Fas^low variants was diminished approximately two- to threefold compared to that observed with wildtype Jurkat cells. However, lysis of the Jurkat Fas^low variants was not completely eliminated, suggesting that part of the cytolytic activity of the clones was independent of Fas. This was supported by anti-Fas antibody blocking studies.

Inhibition of Jurkat cell cytolysis by the clones was also achieved using a nonlytic anti-Fas antibody, M38 (24). Fig. 5 D shows that the blocking of cytolysis with M38 was partial, achieving 30–50% inhibition at the highest concentration of antibody (10 µg/ml), whereas control mouse Ig did not block cytolysis. In vitro cytolysis consists of a calcium-independent component mediated by Fas and a calcium-dependent component delivered by perforin (18–20). Blocking perforin action by chelation of calcium with EGTA also resulted in partial inhibition of Jurkat cytolysis, which could then be blocked almost completely by the further addition of anti-Fas antibody (Fig. 5 D). A third method of disrupting Fas-Fas_L interaction used the Fas-Fc fusion protein. Fig. 5 E shows that Fas-Fc, but not IL4RFc, partially blocked cytolysis of Jurkat cells by the clones, though to a slightly lesser extent than did nonlytic anti-Fas antibody.

The above findings show that clones derived from synovial fluid express prolonged and high levels of Fas_L and suggest that cells preferentially lyse Fas^high cells. To directly assess whether uncloned synovial cells function in a similar manner, Fas_L expression was determined on synovial lymphocytes after Borrelia stimulation. As shown in Fig. 6 A, 7 d after activation, Fas_L expression was confined exclusively to a major proportion of the cells. Fas_L was still expressed by at least 50% of the synovial cells for as long as 11 d after Borrelia stimulation.

View larger version (85K): [in this window] [in a new window] [Download PPT slide]   Figure 6 Synovial cells express FasL and their presence correlates with apoptosis of synovial CD4+ cells. (A) Lyme arthritis synovial fluid lymphocytes were stimulated with B. burgdorferi for 5 d and then stained with anti- and monoclonal anti-FasL, A11. (B) Depletion of cells from fresh Lyme arthritis synovial fluid was performed by flow cytometric sorting. Sorted and unsorted synovial fluid lymphocytes from the same specimen were then cultured with B. burgdorferi for 4 d and stained for expression of TCR-, CD4, and CD8. Note the subpopulation of CD4low cells indicated by the white arrow insets, and the percent in that group noted by the number over the arrow. The CD4low cells comprise a larger proportion of the total CD4+ subset in the cultures containing cells (–nondepleted), even though they contained overall a smaller proportion of CD4+ cells compared to the -depleted cultures. These findings were consistent in three experiments. (C) Determination of DNA fragmentation in a second -nondepleted synovial culture using the TUNEL assay combined with surface labeling and flow cytometry. Note that the CD4low subpopulation is the subset undergoing apoptosis.

 
To further assess the contribution of the cells to the loss of synovial CD4⁺ cells, the subset was depleted by flow cytometric sorting and compared to a nondepleted sample of the same specimen after five days of stimulation with B. burgdorferi. During this period, the cells in the nondepleted synovial sample expanded from 4.3% to 11% (Fig. 6 B). This was accompanied by a decreased proportion of CD4⁺ cells, from 35.6 to 25.3%. In striking contrast, the -depleted population contained only 4% cells after 5 d and manifested a predominance of CD4⁺ cells (40.8%)(Fig. 6 B). In addition, the CD4⁺ cells in the 4-day cultures contained a subpopulation of CD4^low cells which comprised a greater proportion of the total CD4⁺ cells in the -replete than the -depleted specimen (Fig. 6 B, arrow inset). These CD4^low cells represented apoptotic cells, as determined by the TUNEL assay combined with surface staining and analyzed by flow cytometry (Fig. 6 C ). Smaller proportions of apoptotic cells were also observed in the CD8⁺ and ⁺ subsets. Observations similar to these have been made with depletion of two additional Lyme synovial fluid specimens, as well as by noting a depletion of CD4⁺ cells when V1 cloned T cells were added to cultures of PBL that have been stimulated with B. burgdorferi (data not shown).

To assess whether the appearance of the apoptotic CD4^low subset in the -replete cultures was in part Fas-mediated, Fas_L was blocked using the Fas-Fc fusion protein. Synovial fluid lymphocytes were stimulated with B. burgdorferi in the presence of either no additives, Fas-Fc, or control mouse IgG. As shown in Fig. 7, the appearance of apoptotic CD4^low cells occurred beginning about five days after Borrelia stimulation. The proportion of this subset increased dramatically thereafter in all cultures except that containing Fas-Fc. The findings support the view that the subset induces apoptosis of synovial CD4⁺ cells at least partly through Fas/Fas_L interactions.

View larger version (24K): [in this window] [in a new window] [Download PPT slide]   Figure 7 FasL inhibition prevents appearance of CD4low apoptotic subset. Lyme arthritis synovial fluid mononuclear cells were stimulated with B. burgdorferi (B.b.) in the presence of no additives (closed circles), or 10 µg/ml of either Fas-Fc (closed squares), or murine IgG (open circles). After the indicated day of stimulation, cultures were analyzed for expression of CD4, CD8, and . Shown is the expression of apoptotic CD4low cells (as identified by TUNEL in Fig. 6 C ) as a percentage of the total CD4+ cells. The results are representative of two experiments.

 

	Discussion

Top Abstract Materials and Methods Results Discussion References

 
The collective observations suggest an immunoregulatory circuit whereby synovial V1 T cells bearing high levels of Fas_L selectively restrict the expansion of infiltrating inflammatory Fas^high CD4⁺ lymphocytes through cytolysis in a Fas-dependent manner. The findings are in agreement with recent studies showing that Fas_L mRNA expression by T cells is highest in the subset (21). Not only were levels of surface Fas_L high on the V1 clones, they remained elevated for considerably longer periods than similarly activated β T cells. This may serve to explain the broad spectrum of cytolytic activity that has frequently been observed for many cells (2, 16). The results parallel other recent descriptions of immunosuppression resulting from constitutive expression of Fas_L by Sertoli cells in the testis (22), and by components of the eye (23).

The current findings may also bear on observations that collagen-induced arthritis in mice (34) and adjuvant arthritis in rats (35) are both more severe following administration of anti- antibody. Collagen-induced arthritis is also more aggressive in mice bearing a genetic deletion of the locus (Lefrancois, L., personal communication). Similar results have been observed in a model of orchitis in which depletion accelerated the inflammatory response (36). T cells have also been observed to modulate the functional profile of CD4⁺ cells. In certain instances this has manifested as selectively inhibiting T_H2-dependent cytokine responses, such as IgE production in an allergy model (37) and Coxsackievirus-induced myocarditis (38). The resulting T_H1 bias may be due solely to the production of the T_H1-type cytokine, IFN, by cells (37), but may also reflect a greater sensitivity of T_H2 cells to Fas-mediated apoptosis. In this regard, it is noteworthy that B. burgdorferi– reactive CD4⁺ T cells from Lyme arthritis patients express a T_H1 cytokine phenotype (39). Studies are in progress to determine whether a T_H1 enrichment results in the residual CD4⁺ synovial T cells following stimulation with B. burgdorferi.

Lyme arthritis synovial T cells also represent a rare instance where T cell clones obtained from a human infectious disease manifest a proliferative response in the presence of the causative agent. This does not establish that Lyme arthritis synovial cells are responding directly to a Borrelial component. It is entirely possible that B. burgdorferi induces the appearance of surface molecules to which V1 cells respond secondarily. Cutaneous lesions in leprosy also contain T cells that react to the causative agent, Mycobacterium leprae (9). The repertoire of cells that react to mycobacterial products is restricted in both humans and mice (11, 40), and in some instances involves recognition of nonpeptide components such as prenyl pyrophosphates (15, 41). Conceivably, cells in Lyme arthritis may also recognize nonprotein components of B. burgdorferi. On balance, the current findings are consistent with the concept that cells participate in the defense against infectious agents while modulating the immune response through Fas-mediated apoptosis.

	Acknowledgments

 
We thank Colette Charland (The University of Vermont College of Medicine, Burlington, VT) for assistance with flow cytometry and Roberta Christie (The University of Vermont College of Medicine, Burlington, VT) for preparation of the manuscript.

Submitted: 22 May 1996
Revised: 9 September 1996

¹Abbreviation used in this paper: PBL, peripheral blood lymphocytes.

	References

Top Abstract Materials and Methods Results Discussion References

 

1 Groh V, Porcelli S, Fabbi M, Lanier LL, Picker LJ, Anderson T, Warnke RA, Bhan AT, Strominger JL & Brenner MB. Human lymphocytes bearing T cell receptor are phenotypically diverse and evenly distributed throughout the lymphoid system, J Exp Med, 1989, 169, 1277–1294.[Abstract/Free Full Text]

2 Goodman T & Lefrancois L. Expression of the T-cell receptor on intestinal CD8+ intraepithelial lymphocytes, Nature (Lond), 1988, 333, 855–857.[Medline]

3 Spencer J, Isaacson PG, Diss TC & MacDonald TT. Expression of disulfide-linked and non-disulfide-linked forms of the T cell receptor heterodimer in human intestinal intraepithelial lymphocytes, Eur J Immunol, 1989, 19, 1335–1344.[Medline]

4 Augustin A, Kubo RT & Sim G-K. Resident pulmonary lymphocytes expressing the T-cell receptor, Nature (Lond), 1989, 340, 239–241.[Medline]

5 Carding SR, Allan W, Kyes S, Hayday A, Bottomly K & Doherty PC. Late dominance of the inflammatory process in murine influenza by ⁺T cells, J Exp Med, 1990, 172, 1225–1231.[Abstract/Free Full Text]

6 Brennan F, Londei M, Jackson AM, Hercend T, Brenner MB, Maini RN & Feldman M. T-cell expressing / chain receptors in rheumatoid arthritis, J Autoimmun, 1988, 1, 319–326.[Medline]

7 Holoshitz J, Koning F, Coligan JE, De Bruyn J & Strober S. Isolation of CD4-CD8- mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid, Nature (Lond), 1989, 339, 226–229.[Medline]

8 Emoto M, Danbara H & Yoshikai Y. Induction of T cells in murine salmonellosis by an avirulent but not by a virulent strain of Salmonella choleraesuis. , J Exp Med, 1992, 176, 363–372.[Abstract/Free Full Text]

9 Modlin RL, Pirmez C, Hofman FM, Turigion V, Uyemura K, Rea TH, Bloom BR & Brenner MB. Lymphocytes bearing antigen-specific T cell receptors accumulate in human infectious disease lesions, Nature (Lond), 1989, 339, 544–548.[Medline]

10 Haregewoi A, Soman G, Hom RC & Finberg RW. Human ⁺T cells respond to mycobacterial heatshock protein, Nature (Lond), 1989, 340, 309–312.[Medline]

11 O'Brien RL, Happ MP, Dallas A, Palmer E, Kubo R & Born WK. Stimulation of a major subset of lymphocytes expressing T cell receptor by an antigen derived from Mycobacterium tuberculosis. , Cell, 1989, 57, 667–674.[Medline]

12 Janis EM, Kaufmann SHE, Schwartz RH & Pardoll DM. Activation of T cells in the primary immune response to Mycobacterium tuberculosis. , Science (Wash DC), 1989, 244, 713–716.[Abstract/Free Full Text]

13 Born WK, Hall L, Dallas A, Boymel J, Shinnick T, Young D, Brennan P & O'Brien R. Recognition of a peptide antigen by heat shock-reactive T lymphocytes, Science (Wash DC), 1990, 249, 67–69.[Abstract/Free Full Text]

14 Rust CJJ, Verreck F, Vietor H & Konig F. Specific recognition of staphylococcal enterotoxin A by human T cell bearing receptors, Nature (Lond), 1990, 346, 572–574.[Medline]

15 Tanaka Y, Morita CT, Tanaka Y, Nieves E, Brenner MB & Bloom BR. Natural and synthetic non-peptide antigens recognized by human T cells, Nature (Lond), 1995, 375, 155–158.[Medline]

16 Wright A, Lee JE, Link MP, Smith SD, Carroll W, Levy R, Clayberger C & Krensky A M. Cytotoxic T lymphocytes specific for self tumor immunoglobulin express T cell receptor chains, J Exp Med, 1990, 169, 1557–1564.[Medline]

17 Nagata S. Fas and Fas ligand: a death factor and its receptor, Adv Immunol, 1994, 57, 129–144.[Medline]

18 Rouvier E, Luciani M-F & Golstein P. Fas involvement in Ca²⁺-independent T cell-mediated cytotoxicity, J Exp Med, 1993, 177, 195–200.[Abstract/Free Full Text]

19 Kagi D, Vignaux F, Lederman B, Burki K, Depraetere V, Nagata S, Hengartner H & Golstein P. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity, Science (Wash DC), 1994, 265, 528–530.[Abstract/Free Full Text]

20 Lowin B, Hahne M, Mattmann C & Tschopp J. Cytolytic T cell cytotoxicity is mediated through perforin and Fas lytic pathways, Nature (Lond), 1994, 370, 650–652.[Medline]

21 Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K & Nagata S. Expression of the Fas ligand in cells of T cell lineage, J Immunol, 1995, 154, 3806–3813.[Abstract]

22 Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A & Duke RC. A role for CD95 ligand in preventing graft rejection, Nature (Lond), 1995, 377, 630–632.[Medline]

23 Griffith TS, Brunner T, Fletcher SM, Green DG & Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege, Science (Wash DC), 1995, 270, 1189–1192.[Abstract/Free Full Text]

24 Alderson MR, Armitage RJ, Marakosky E, Tough TW, Roux E, Schooley K, Ramsdell F & Lynch DH. Fas transduces activation signals in normal human T lymphocytes, J Exp Med, 1993, 178, 2231–2235.[Abstract/Free Full Text]

25 French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Muller C & Tschopp J. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover, J Cell Biol, 1996, 133, 335–343.[Abstract/Free Full Text]

26 Alderson MR, Tough TW, Braddy S, Davis-Smith T, Roux E, Schooley K, Miller RE & Lynch DH. Regulation of apoptosis and T cell activation by Fas-specific mAb, Int Immunol, 1994, 6, 1799–1806.[Abstract/Free Full Text]

27 Mariani SM, Matiba B, Baumler C & Krammer PH. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases, Eur J Immunol, 1995, 25, 2303–2307.[Medline]

28 Roessner K, Fikrig E, Russell JQ, Cooper SM, Flavell RA & Budd RC. Prominent T lymphocyte response to Borellia burgdorferifrom peripheral blood of unexposed donors, Eur J Immunol, 1994, 24, 320–324.[Medline]

29 Cooper SM, Roessner KD, Naito-Hoopes M, Howard DB, Gaur LK & Budd RC. Increased usage of Vβ2 and Vβ6 in rheumatoid synovial fluid T cells, Arthritis Rheum, 1994, 37, 1627–1636.[Medline]

30 De Libero G, Rocci MP, Casorati G, Giachino C, Oderda G, Tavassoli K & Migone N. T cell receptor heterogeneity in T cell clones from intestinal biopsies of patients with celiac disease, Eur J Immunol, 1993, 23, 499–504.[Medline]

31 Gavrieli Y, Sherman Y & Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation, J Cell Biol, 1992, 119, 493–498.[Abstract/Free Full Text]

32 Sgorc R, Boeck G, Dietrich H, Gruber J, Recheis H & Wick G. Simultaneous determination of cell surface antigens and apoptosis, Trends Genet, 1994, 10, 41–42.[Medline]

33 Parker CM, Groh V, Band H, Porcelli SA, Morita C, Fabbi M, Glass D, Strominger JL & Brenner MB. Evidence for extrathymic changes in the T cell receptor repertoire, J Exp Med, 1990, 171, 1597–1612.[Abstract/Free Full Text]

34 Peterman GM, Spencer C, Sperling AI & Bluestone JA. Role of T cells in murine collagen-induced arthritis, J Immunol, 1993, 151, 6546–6558.[Abstract]

35 Pelegri C, Kuhlein P, Buchner E, Schmidt CB, Franch A, Castell M, Hunig T, Emmrich F & Kinne RW. Depletion of / T cells does not prevent or ameliorate, but rather aggravates, rat adjuvant arthritis, Arthritis Rheum, 1996, 38, 204–215.

36 Mukasa A, Hiromatsu K, Matsuzaki G, O'Brien R, Born W & Nomoto K. Bacterial infection of the testis leading to autoaggressive immunity triggers apparently opposed responses of β and T cells, J Immunol, 1995, 155, 2047–2056.[Abstract]

37 McMenamin C, Pimm C, McKersey M & Holt PG. Regulation of IgE responses to inhaled antigen in mice by antigen-specific T cells, Science (Wash DC), 1994, 265, 1869–1871.[Abstract/Free Full Text]

38 Huber SA, Mortensen A & Moulton G. Modulation of cytokine expression by CD4+ T cells during Coxsackievirus B3 infection of Balb/c mice initiated by cells expressing the + T cell receptor, J Virol, 1996, 70, 3039–3044.[Abstract]

39 Yssel H, Shanafelt M-C, Soderberg C, Schneidet PV, Anzola J & Peltz G. Borrelia burgdorferiactivates T helper type 1-like T cell subset in Lyme arthritis, J Exp Med, 1991, 174, 593–603.[Abstract/Free Full Text]

40 Haas V, Pereira P & Tonegawa S. Gamma/delta cells, Annu Rev Immunol, 1993, 11, 637–685.[Medline]

41 Morita CT, Beckman EM, Bakowski JF, Tamaka Y, Band H, Bloom BR, Golan DE & Brenner MB. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human T cells, Immunity, 1995, 3, 495–507.[Medline]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This article has been cited by other articles:

• Collins, C., Shi, C., Russell, J. Q., Fortner, K. A., Budd, R. C. (2008). Activation of {gamma}{delta} T Cells by Borrelia burgdorferi Is Indirect via a TLR- and Caspase-Dependent Pathway. J. Immunol. 181: 2392-2398 [Abstract] [Full Text]  
• Zachariadis, O., Cassidy, J. P., Brady, J., Mahon, B. P. (2006). {gamma}{delta} T Cells Regulate the Early Inflammatory Response to Bordetella pertussis Infection in the Murine Respiratory Tract. Infect. Immun. 74: 1837-1845 [Abstract] [Full Text]  
• Collins, C., Wolfe, J., Roessner, K., Shi, C., Sigal, L. H., Budd, R. C. (2005). Lyme Arthritis Synovial {gamma}{delta} T Cells Instruct Dendritic Cells via Fas Ligand. J. Immunol. 175: 5656-5665 [Abstract] [Full Text]  
• Holm, G. H., Gabuzda, D. (2005). Distinct Mechanisms of CD4+ and CD8+ T-Cell Activation and Bystander Apoptosis Induced by Human Immunodeficiency Virus Type 1 Virions. J. Virol. 79: 6299-6311 [Abstract] [Full Text]  
• Ponomarev, E. D., Dittel, B. N. (2005). {gamma}{delta} T Cells Regulate the Extent and Duration of Inflammation in the Central Nervous System by a Fas Ligand-Dependent Mechanism. J. Immunol. 174: 4678-4687 [Abstract] [Full Text]  
• Dalton, J. E., Howell, G., Pearson, J., Scott, P., Carding, S. R. (2004). Fas-Fas Ligand Interactions Are Essential for the Binding to and Killing of Activated Macrophages by {gamma}{delta} T Cells. J. Immunol. 173: 3660-3667 [Abstract] [Full Text]  
• Das, H., Sugita, M., Brenner, M. B. (2004). Mechanisms of V{delta}1 {gamma}{delta} T Cell Activation by Microbial Components. J. Immunol. 172: 6578-6586 [Abstract] [Full Text]  
• Klimpel, G. R., Matthias, M. A., Vinetz, J. M. (2003). Leptospira interrogans Activation of Human Peripheral Blood Mononuclear Cells: Preferential Expansion of TCR{gamma}{delta}+ T Cells vs TCR{alpha}{beta}+ T Cells. J. Immunol. 171: 1447-1455 [Abstract] [Full Text]  
• Roessner, K., Wolfe, J., Shi, C., Sigal, L. H., Huber, S., Budd, R. C. (2003). High Expression of Fas Ligand by Synovial Fluid-Derived {gamma}{delta} T Cells in Lyme Arthritis. J. Immunol. 170: 2702-2710 [Abstract] [Full Text]  
• Huber, S. A., Sartini, D., Exley, M. (2002). V{gamma}4+ T Cells Promote Autoimmune CD8+ Cytolytic T-Lymphocyte Activation in Coxsackievirus B3-Induced Myocarditis in Mice: Role for CD4+ Th1 Cells. J. Virol. 76: 10785-10790 [Abstract] [Full Text]  
• Huber, S., Shi, C., Budd, R. C. (2002). {gamma}{delta} T Cells Promote a Th1 Response during Coxsackievirus B3 Infection In Vivo: Role of Fas and Fas Ligand. J. Virol. 76: 6487-6494 [Abstract] [Full Text]  
• Bank, I, Cohen, L, Mouallem, M, Farfel, Z, Grossman, E, Ben-Nun, A (2002). {gamma}{delta} T cell subsets in patients with arthritis and chronic neutropenia. Ann Rheum Dis 61: 438-443 [Abstract] [Full Text]  
• Skeen, M. J., Rix, E. P., Freeman, M. M., Ziegler, H. K. (2001). Exaggerated Proinflammatory and Th1 Responses in the Absence of gamma /delta T Cells after Infection with Listeria monocytogenes. Infect. Immun. 69: 7213-7223 [Abstract] [Full Text]  
• Naiman, B. M., Alt, D., Bolin, C. A., Zuerner, R., Baldwin, C. L. (2001). Protective Killed Leptospira borgpetersenii Vaccine Induces Potent Th1 Immunity Comprising Responses by CD4 and gamma delta T Lymphocytes. Infect. Immun. 69: 7550-7558 [Abstract] [Full Text]  
• Bockenstedt, L. K., Kang, I., Chang, C., Persing, D., Hayday, A., Barthold, S. W. (2001). CD4+ T Helper 1 Cells Facilitate Regression of Murine Lyme Carditis. Infect. Immun. 69: 5264-5269 [Abstract] [Full Text]  
• Huber, S. A., Graveline, D., Born, W. K., O'Brien, R. L. (2001). Cytokine Production by V{gamma}+-T-Cell Subsets Is an Important Factor Determining CD4+-Th-Cell Phenotype and Susceptibility of BALB/c Mice to Coxsackievirus B3-Induced Myocarditis. J. Virol. 75: 5860-5869 [Abstract] [Full Text]  
• Huber, S. A., Graveline, D., Newell, M. K., Born, W. K., O'Brien, R. L. (2000). V{gamma}1+ T Cells Suppress and V{gamma}4+ T Cells Promote Susceptibility to Coxsackievirus B3-Induced Myocarditis in Mice. J. Immunol. 165: 4174-4181 [Abstract] [Full Text]  
• Mincheva-Nilsson, L., Nagaeva, O., Sundqvist, K.-G., Hammarstrom, M.-L., Hammarstrom, S., Baranov, V. (2000). {gamma}{delta}T cells of human early pregnancy decidua: evidence for cytotoxic potency. Int Immunol 12: 585-596 [Abstract] [Full Text]  
• Zarozinski, C. C., McNally, J. M., Lohman, B. L., Daniels, K. A., Welsh, R. M. (2000). Bystander Sensitization to Activation-Induced Cell Death as a Mechanism of Virus-Induced Immune Suppression. J. Virol. 74: 3650-3658 [Abstract] [Full Text]  
• Belles, C., Kuhl, A., Nosheny, R., Carding, S. R. (1999). Plasma Membrane Expression of Heat Shock Protein 60 In Vivo in Response to Infection. Infect. Immun. 67: 4191-4200 [Abstract] [Full Text]  
• Vincent, M. S., Roessner, K., Sellati, T., Huston, C. D., Sigal, L. H., Behar, S. M., Radolf, J. D., Budd, R. C. (1998). Lyme Arthritis Synovial {gamma}{delta} T Cells Respond to Borrelia burgdorferi Lipoproteins and Lipidated Hexapeptides. J. Immunol. 161: 5762-5771 [Abstract] [Full Text]  
• Lohman, B. L., Welsh, R. M. (1998). Apoptotic Regulation of T Cells and Absence of Immune Deficiency in Virus-Infected Gamma Interferon Receptor Knockout Mice. J. Virol. 72: 7815-7821 [Abstract] [Full Text]  
• Li, B., Bassiri, H., Rossman, M. D., Kramer, P., Eyuboglu, A. F.-O., Torres, M., Sada, E., Imir, T., Carding, S. R. (1998). Involvement of the Fas/Fas Ligand Pathway in Activation-Induced Cell Death of Mycobacteria-Reactive Human {gamma}{delta} T Cells: A Mechanism for the Loss of {gamma}{delta} T Cells in Patients with Pulmonary Tuberculosis. J. Immunol. 161: 1558-1567 [Abstract] [Full Text]  
• Roessner, K., Trivedi, H., Gaur, L., Howard, D., Aversa, J., Cooper, S. M., Sigal, L. H., Budd, R. C. (1998). Biased T-Cell Antigen Receptor Repertoire in Lyme Arthritis. Infect. Immun. 66: 1092-1099 [Abstract] [Full Text]  
• Arnulf, B., Copie-Bergman, C., Delfau-Larue, M.-H., Lavergne-Slove, A., Bosq, J., Wechsler, J., Wassef, M., Matuchansky, C., Epardeau, B., Stern, M., Bagot, M., Reyes, F., Gaulard, P. (1998). Nonhepatosplenic gamma delta T-Cell Lymphoma: A Subset of Cytotoxic Lymphomas With Mucosal or Skin Localization. Blood 91: 1723-1731 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF, 342K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Vincent, M. S. Articles by Budd, R. C. Search for Related Content PubMed PubMed Citation Articles by Vincent, M. S. Articles by Budd, R. C. Pubmed/NCBI databases Medline Plus Health Information Joint Disorders Lyme Disease Social Bookmarking                            What's this?